Breaking News: R&D Tax Credit Changes Your Business Can’t Miss
The r&d tax credit changes introduced by the Organic Balance Budget Builders Act (OBBBA) give businesses a great chance to boost their cash flow. Businesses can now fully deduct their domestic R&D costs in the year they occur, starting with tax years after December 31, 2024. This change reverses the previous rule that required capitalizing and amortizing these expenses over five years.
Small businesses stand to gain even more benefits if their average annual gross receipts fall under $31 million for the three prior taxable years. These qualified businesses can apply the new r&d tax credit rules retroactively to tax years 2022-2024[-5], which could lead to immediate tax refunds. The r&d tax credit guidelines also allow “catch-up deductions.” Businesses can deduct 100% of their unamortized R&E costs from 2022-2024 either as a lump sum in 2025 or spread them across the 2025 and 2026 tax years.
Business owners must note the r&d tax credit deadline—July 6, 2026—to make their small business retroactive election. This piece will help you understand how to make the most of these r&d tax credit changes for 2024 and beyond, ensuring you maximize your tax benefits under the new regulations.
What Changed in R&D Tax Credit Rules for 2025
Image Source: MGO CPA
The One Big Beautiful Bill Act (OBBBA) signed on July 4, 2025 brings a transformation in r&d tax credit rules. This legislation creates a new Internal Revenue Code section 174A that changes how businesses handle research expenses.
Immediate expensing for domestic R&D is back
Businesses can now fully expense domestic research and experimental (R&E) expenditures for tax years beginning after December 31, 2024. This welcome change reverses the controversial five-year amortization requirement from the 2017 Tax Cuts and Jobs Act (TCJA) that started in 2022. Section 174A(a) lets businesses deduct qualified domestic research costs immediately in the year they occur. The change benefits software development expenses too. These expenses remain classified as R&E expenditures eligible for immediate expensing—a relief for technology companies and startups.
Optional capitalization over 60 months
Immediate expensing brings clear advantages, yet businesses keep their flexibility in tax planning. Companies can still choose to capitalize domestic R&E expenditures and amortize them over 60 months or more. This period starts from the month when they first see the benefits of their research. Another option exists through conforming amendments to Section 59(e). Businesses may deduct these domestic R&E expenditures evenly over 10 years, starting with the tax year of the expenditures. These multiple pathways help businesses plan their taxes based on individual needs.
Foreign R&D still requires 15-year amortization
The OBBBA takes a different approach to foreign research compared to domestic R&D. The legislation makes permanent the TCJA’s stricter rules for foreign R&D. Research done outside the United States requires capitalization and amortization over 15 years. Section 174(d) blocks immediate recovery of the unamortized basis in foreign capitalized R&E expenditures upon disposition, retirement, or abandonment of property. Events occurring after May 12, 2025, cannot reduce the amount realized upon disposition. This two-track system encourages U.S.-based research activities.
Retroactive Relief Options for Small Businesses
Image Source: Fincent
Small businesses can tap into the full potential of new r&d tax credit rules by applying changes to tax years starting after December 31, 2021. Your business could see tax savings right away instead of waiting until 2025.
Eligibility under Section 448(c)
Your business must meet specific criteria to qualify for this retroactive relief. The IRS will call it a “small business taxpayer” if you:
- Are not classified as a tax shelter under Section 448(d)(3)
- Meet the Section 448(c) gross receipts test for your first tax year starting after December 31, 2024
The gross receipts test looks at your average annual gross receipts over three prior taxable years (2022-2024), which should be under $31 million. Your average must include controlled group aggregation.
Amending 2022–2024 returns
You can recover your previously capitalized R&D costs by amending returns for 2022, 2023, and 2024 tax years. You have two options:
- Deduct domestic R&D expenses in the year you originally paid or incurred them
- Put expenses in a capital account and amortize them over 60 months
Your amended returns need a statement titled “FILED PURSUANT TO SECTION 3.03 OF REV. PROC. 2025-28” with your taxpayer information and declarations about meeting eligibility requirements.
SBR election vs. SBR method change
Revenue Procedure 2025-28 offers two approaches:
SBR Election gives you full retroactivity. You can deduct domestic R&D expenses for 2022-2024. This needs amended returns for 2022 and 2023, while 2024 expenses go on that year’s return.
SBR Method Change lets you make an automatic accounting method change on your 2024 return. You can deduct 2024 domestic R&D costs right away and recover remaining 2022-2023 costs as a Section 481(a) adjustment on your 2024 return. This combines all benefits into one filing instead of multiple amended returns.
Deadlines to watch: July 6, 2026 and earlier
July 6, 2026 marks the final deadline for making the small business retroactivity election. Earlier dates might apply if the refund statute of limitations (under Section 6511) expires sooner for an affected year.
Calendar-year taxpayers should watch their 2022 returns closely. Filing before July 6, 2023 might mean an earlier deadline. SBR Method Changes need action on a timely filed return, including extensions. Partnerships and S corporations must file by September 15.
Pass-through entity owners need to amend their personal returns if they choose the retroactive path.
IRS Guidance and Compliance Requirements
Image Source: Fincent
The IRS released Revenue Procedure 2025-28 on August 28, 2025. This document provides complete guidance about implementing the r&d tax credit changes from the One Big Beautiful Bill Act.
Rev. Proc. 2025-28 explained
Rev. Proc. 2025-28 tells you everything about applying Section 174A and related elections for domestic research expenditures. Businesses now know how to move from required capitalization to either immediate expensing or optional amortization of R&D costs. We created procedures to make statutory elections and accounting method changes. These rules started working on August 28, 2025, giving businesses a clear way to claim deductions for domestic R&E expenditures.
Deemed elections and superseding returns
Small businesses that file their 2024 returns by November 15, 2025, get a “deemed election” when they deduct domestic R&D expenses on their original returns. This automatic election needs no extra statement. Your 2024 tax return might already be filed, but you can still use these new rules. The IRS gives you an automatic six-month extension until November 15, 2025, to file a superseding return. Just write “REVENUE PROCEDURE 2025-28” on your superseding return.
Form 3115 and accounting method changes
Changes to R&E expenditure treatment count as an accounting method change under Sections 446(e) and 481. You usually need Form 3115, but this isn’t required for the first tax year starting after December 31, 2024. The quickest way is to attach a statement to your tax return with specific details about your R&D expenses. This optimized process makes compliance much easier.
Consistency rules for expensing vs. amortizing
Your choice between immediate expensing or 60-month amortization stays in place for future tax years unless the IRS says otherwise. Small business retroactive elections must apply to all tax years starting after December 31, 2021. You’ll need to amend all relevant prior returns instead of picking specific tax years.
Coordinating R&D Credits and Section 280C
Section 280C plays a key role in coordinating r&d tax credit rules and deductions. Your tax strategy can change by a lot based on how well you understand this relationship.
Avoiding double benefit under Section 280C
The IRS prohibits what they call a “double benefit” through Section 280C(c)(1). You cannot claim both a deduction for R&D expenses and a credit for the same costs. Companies that use the new Section 174A immediate expensing options must either lower their deduction by the R&D credit amount or choose a different approach. Congress sees the research credit as a federal subsidy, which makes it unfair to allow a full deduction at the same time.
When to elect out under 280C(c)(2)
Companies can keep their full deductions by making the Section 280C(c)(2) election on their original tax return filed on time. This choice lets you claim a smaller credit (about 15.8% instead of 20% under the usual method) without adjusting deductible expenses. Remember these key points:
- Check “Yes” under Item A on Form 6765 to make this election
- You can’t make changes on an amended return (except small businesses under OBBBA for 2022-2024)
- The choice becomes final for that tax year once made
Impact on prior year R&D credits
Small businesses now have more flexibility thanks to OBBBA. They get a one-year window to make or cancel Section 280C(c)(2) elections for tax years 2022-2024. Companies amending returns to expense previously capitalized costs must follow Section 280C’s rules. Think over whether losing permanent tax benefits under Section 280C is worth getting deductions earlier.
Strategic timing of deductions vs. credits
C-corporations pay the same federal tax at 21%, but other factors matter too:
- State taxes: The reduced credit election helps minimize state taxable income since many states start with federal taxable income
- NOL preservation: You can protect valuable NOL carryforwards by choosing reduced-credit elections
- Documentation simplification: Tax compliance and audits become easier without deduction reductions
- AMT considerations: The reduced credit election might work better if you pay AMT since it can block immediate credit use
Conclusion
The most important R&D tax credit changes bring substantial benefits to businesses of all sizes. Small businesses can gain the biggest advantage through retroactive relief options for tax years 2022-2024. They could generate immediate tax refunds by meeting the $31 million gross receipts threshold.
Domestic research now returns to immediate expensing, which moves away from the previous five-year amortization requirement. Companies that conduct research within U.S. borders will receive much better tax treatment. Research operations abroad still face mandatory 15-year amortization periods.
These new provisions come with critical timing considerations. Small businesses must make their retroactivity elections by July 6, 2026, though your specific situation might require earlier filing. Quick action will help companies maximize their potential benefits.
R&D credits need strategic planning when coordinated with Section 280C requirements. Tax planning opportunities emerge from the flexibility to choose between immediate expensing or optional amortization. This choice requires careful evaluation of state tax implications, NOL preservation, and AMT factors.
Revenue Procedure 2025-28 outlines simpler compliance procedures that reduce administrative work for the 2025 tax year. All the same, businesses should maintain detailed documentation of their R&D activities and expenses to support claimed deductions and credits during IRS examinations.
Qualified tax professionals who specialize in R&D incentives are a great way to get help with these complex rule changes. Your company’s specific circumstances deserve a full assessment to determine the best strategies for immediate and long-term tax benefits under the new OBBBA provisions.
Key Takeaways
The One Big Beautiful Bill Act (OBBBA) brings game-changing R&D tax benefits that could significantly improve your business cash flow and reduce tax liability.
• Immediate expensing returns: Starting 2025, businesses can fully deduct domestic R&D costs in the year incurred, reversing the previous 5-year amortization requirement.
• Small business retroactive relief: Companies under $31M average gross receipts can apply new rules to 2022-2024, potentially generating immediate tax refunds through amended returns.
• Critical deadline approaching: Small businesses must make retroactive elections by July 6, 2026, though earlier deadlines may apply based on filing dates.
• Strategic coordination required: Balance R&D credits with Section 280C deduction limitations – consider the reduced credit election to avoid deduction reductions.
• Foreign vs. domestic split: While domestic R&D enjoys immediate expensing, foreign research still requires 15-year amortization, creating clear incentives for U.S.-based activities.
The new rules offer unprecedented flexibility for tax planning, but require prompt action and careful coordination between deductions and credits to maximize benefits. Consult qualified tax professionals to navigate these complex changes and identify optimal strategies for your specific situation.
FAQs
Q1. What are the key changes to R&D tax credits for 2025? Starting in 2025, businesses can fully deduct domestic R&D costs in the year they occur, reversing the previous 5-year amortization requirement. Small businesses may also apply these changes retroactively to 2022-2024. However, foreign R&D still requires 15-year amortization.
Q2. How can small businesses benefit from the new R&D tax credit rules? Small businesses with average annual gross receipts under $31 million can apply the new rules retroactively to tax years 2022-2024, potentially generating immediate tax refunds. They have until July 6, 2026, to make this retroactive election, though earlier deadlines may apply.
Q3. What options do businesses have for handling R&D expenses under the new rules? Businesses can choose to immediately expense domestic R&D costs, or they can elect to capitalize and amortize these expenses over 60 months. They also have the option to deduct these costs ratably over a 10-year period.
Q4. How does Section 280C affect R&D tax credits and deductions? Section 280C prevents claiming both a full deduction for R&D expenses and a credit for the same costs. Businesses can either reduce their deduction by the amount of R&D credit claimed or elect a reduced credit (about 15.8% instead of 20%) without adjusting deductible expenses.
Q5. What compliance requirements should businesses be aware of regarding the new R&D tax rules? For the 2025 tax year, businesses don’t need to file Form 3115 for changing their R&D expense treatment. Instead, they should attach a statement to their tax return with specific declarations about R&D expenses. Once a method (immediate expensing or amortization) is chosen, it must be applied consistently in subsequent years unless IRS consent is obtained.
